A detailed history of Exane Derivatives transactions in Danaher Corp stock. As of the latest transaction made, Exane Derivatives holds 7,581 shares of DHR stock, worth $2.02 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
7,581
Previous 8,563 11.47%
Holding current value
$2.02 Million
Previous $2.51 Million 23.5%
% of portfolio
1.23%
Previous 0.78%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$237.11 - $299.66 $232,842 - $294,266
-982 Reduced 11.47%
7,581 $1.92 Million
Q1 2022

Apr 22, 2022

BUY
$257.27 - $315.76 $302,292 - $371,018
1,175 Added 15.9%
8,563 $2.51 Million
Q4 2021

Jan 28, 2022

BUY
$292.08 - $329.01 $16,648 - $18,753
57 Added 0.78%
7,388 $2.43 Million
Q3 2021

Oct 26, 2021

SELL
$272.21 - $332.43 $219,945 - $268,603
-808 Reduced 9.93%
7,331 $2.23 Million
Q2 2021

Jul 28, 2021

SELL
$225.08 - $271.69 $71,350 - $86,125
-317 Reduced 3.75%
8,139 $2.18 Million
Q1 2021

Apr 30, 2021

SELL
$212.38 - $245.9 $570,240 - $660,241
-2,685 Reduced 24.1%
8,456 $1.9 Million
Q4 2020

Jan 27, 2021

SELL
$212.5 - $245.46 $1.12 Million - $1.3 Million
-5,281 Reduced 32.16%
11,141 $2.47 Million
Q3 2020

Oct 06, 2020

BUY
$177.16 - $215.33 $85,922 - $104,435
485 Added 3.04%
16,422 $3.54 Million
Q2 2020

Jul 10, 2020

BUY
$128.7 - $176.83 $106,177 - $145,884
825 Added 5.46%
15,937 $2.82 Million
Q1 2020

Apr 17, 2020

BUY
$121.39 - $169.05 $254,069 - $353,821
2,093 Added 16.08%
15,112 $2.09 Million
Q4 2019

Jan 22, 2020

BUY
$133.47 - $153.48 $616,097 - $708,463
4,616 Added 54.93%
13,019 $2 Million
Q3 2019

Oct 15, 2019

BUY
$135.4 - $146.47 $31,006 - $33,541
229 Added 2.8%
8,403 $1.21 Million
Q2 2019

Jul 12, 2019

BUY
$124.88 - $143.73 $45,581 - $52,461
365 Added 4.67%
8,174 $0
Q1 2019

Apr 24, 2019

BUY
$97.62 - $132.29 $660,692 - $895,338
6,768 Added 650.14%
7,809 $0
Q3 2018

Oct 24, 2018

SELL
$98.13 - $108.9 $4,513 - $5,009
-46 Reduced 4.23%
1,041 $0
Q2 2018

Jul 19, 2018

SELL
$96.1 - $103.24 $7,015 - $7,536
-73 Reduced 6.29%
1,087 $0
Q1 2018

Apr 30, 2018

SELL
$92.16 - $103.8 $7,833 - $8,823
-85 Reduced 6.83%
1,160 $0
Q4 2017

Jan 29, 2018

SELL
$85.26 - $94.62 $5,115 - $5,677
-60 Reduced 4.6%
1,245 $0
Q3 2017

Oct 18, 2017

BUY
$79.29 - $88.45 $103,473 - $115,427
1,305
1,305 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $194B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.